Xgene Pharmaceutical
Shanghai
About Xgene Pharmaceutical
Xgene Pharmaceutical is a late-clinical stage, venture-backed international company that uses proprietary linker technology to develop novel, multimodal conjugated molecules for the treatment of neurological disorders. Current programs are aimed at increasing the efficacy and tolerability of pain medications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $60.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2022)
- Website: xgenepharm.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/xgene-pharmaceutical-31864 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.